Success Metrics

Clinical Success Rate
94.1%

Based on 16 completed trials

Completion Rate
94%(16/17)
Active Trials
1(5%)
Results Posted
44%(7 trials)
Terminated
1(5%)

Phase Distribution

Ph phase_2
4
19%
Ph not_applicable
3
14%
Ph phase_3
4
19%
Ph phase_4
8
38%
Ph early_phase_1
1
5%

Phase Distribution

1

Early Stage

4

Mid Stage

12

Late Stage

Phase Distribution20 total trials
Early Phase 1First-in-human
1(5.0%)
Phase 2Efficacy & side effects
4(20.0%)
Phase 3Large-scale testing
4(20.0%)
Phase 4Post-market surveillance
8(40.0%)
N/ANon-phased studies
3(15.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

94.1%

16 of 17 finished

Non-Completion Rate

5.9%

1 ended early

Currently Active

1

trials recruiting

Total Trials

21

all time

Status Distribution
Active(2)
Completed(16)
Terminated(1)
Other(2)

Detailed Status

Completed16
unknown2
Not yet recruiting1
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
21
Active
1
Success Rate
94.1%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (5.0%)
Phase 24 (20.0%)
Phase 34 (20.0%)
Phase 48 (40.0%)
N/A3 (15.0%)

Trials by Status

unknown210%
not_yet_recruiting15%
terminated15%
recruiting15%
completed1676%

Recent Activity

Clinical Trials (21)

Showing 20 of 21 trialsScroll for more
NCT07394036Phase 2

Effect of Ipratropium Bromide on EILO

Not Yet Recruiting
NCT06074185Phase 2

Treating Respiratory Emergencies in Children Study

Completed
NCT04617015Early Phase 1

Defining and Treating Depression-related Asthma

Completed
NCT04315558Phase 2

Revefenacin in Acute Respiratory Insufficiency in COPD

Completed
NCT05550402Not Applicable

Role of Parasympathetic Activity in Mild to Severe Asthma With Fixed Airway Obstruction (PARASMA Study)

Recruiting
NCT01691079Phase 4

Effectiveness of Ipratropium Bromide in Preventing Exercise-induced Bronchoconstriction in Athletes

Completed
NCT03136120

Cryobiopsy Study to Assess Drug Distribution in Subjects With Suspected Interstitial Lung Disease

Completed
NCT03747536Phase 2

Ipratropium Bromide Spray as Treatment for Sialorrhea in Children

Unknown
NCT01943552Phase 4

Ipratropium Bromide in Peri-Operative COPD

Completed
NCT00588406Phase 3

Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room.

Completed
NCT02584738Phase 4

Nebulized Magnesium Sulfate as an Adjunct to Standard Therapy in Asthma Exacerbation

Unknown
NCT02296047Not Applicable

Ventilation-drive Coupling to Evaluate The Efficacy of Inhaled Bronchodilators in Patients With COPD

Completed
NCT02235428Phase 4

Study to Assess the Efficacy of Ipratropium Bromide Associated With High Dose Salbutamol by Repeated Nebulisation Versus Repeat Nebulisation of Salbutamol Alone, in Acute Asthmatic Attacks in Young Children

Terminated
NCT00928746Phase 3

Actuation Indicator Trial in Patients With COPD

Completed
NCT02177253Phase 3

Ipratropium Bromide/Salbutamol Delivered by the Respimat® Inhaler Compared to Ipratropium Bromide Respimat®, COMBIVENT® Inhalation Aerosol and Placebo in Adults With Chronic Obstructive Pulmonary Disease

Completed
NCT00393367Phase 4

Budesonide Inhalation Suspension for Acute Asthma in Children

Completed
NCT00202176Phase 4

Effects of Bronchodilators in Mild Chronic Obstructive Pulmonary Disease (COPD)

Completed
NCT00807534Not Applicable

Sensitivity of New Exercise Tests in Chronic Obstructive Pulmonary Disease (COPD)

Completed
NCT01136421Phase 3

Magnesium Sulfate Versus Ipratropuim Bromide in Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Completed
NCT00911651Phase 4

Study to Assess the Effect of Salbutamol and Ipratropium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients

Completed

Drug Details

Intervention Type
DRUG
Total Trials
21